Trillium Therapeutics Inc Based In Cambridgemassachusettswas A Clinical Stage Immuno Oncology Company Dedicated To Developing Therapies For Cancer Treatmentfounded In 2004It Specialized In Biologic And Small Molecule Therapies That Target Immune Evasion Mechanisms In Cancerin November 2021Trillium Was Acquired By Pfizer Incfor $2 26 Billionand Its Operations Were Integrated Into Pfizerae S Oncology Division The Company Developed Several Innovative Therapiesincluding Tti 621 And Tti 622Both Designed To Block The Cd47Donae T Eat Mesignal To Enhance Tumor Destruction By Macrophagestti 10001A Small Molecule Sting Agonistaimed To Activate Innate Immune Responses Against Tumorstrillium Focused On Treating Hematologic Cancers And Solid Tumorswith Its Programs Now Advanced Under Pfizer S Oversight
No conferences found for this company.
| Company Name | Trillium Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
